학술논문

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
Document Type
Article
Source
In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 April 2024, 42(12):1378-1390)
Subject
Language
English
ISSN
15277755